GT
CBAY

Glenmede Trust’s Cymabay Therapeutics CBAY Stock Holding History

Glenmede Trust’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-29,373
Closed -$694K – 1396
2023
Q4 		$694K Sell
29,373
-8,521
-22% -$201K ﹤0.01% 803
2023
Q3 		$565K Buy
+37,894
New +$565K ﹤0.01% 808
2020
Q4 		– Sell
-273
Closed -$1K – 2358
2020
Q3 		$1K Buy
+273
New +$1K ﹤0.01% 2416